This is how drugs interact with the body, typically by interacting with macromolecular targets such as receptors and enzymes.

learn more… | top users | synonyms

0
votes
0answers
21 views

What is the distribution of agent on plasma proteins in ECF?

I am studying Montelukast here: Montelukast is more than 99% bound to plasma proteins. The steady state volume of distribution of montelukast averages 8 to 11 liters. Studies in rats with ...
3
votes
1answer
39 views

Why are many anti-malaria drugs gap junction antagonists?

Why are many anti-malaria drugs gap junction antagonists? My professor recently just mentioned that many of the anti-malaria drugs block gap junctions. i am wondering if this blocking is important ...
1
vote
0answers
22 views

Pharmacodynamics of Ethinyl estradiol + Drospirenone and interactions with istotertinoin

Does pharmacodynamics of Ethinyl estradiol + Drospirenone in OCP pills like (Yaz, Yasminelle etc.) while using isotretinoin (Axotret, Roaccutane etc.) is changed? Does isotretinoin weakens the OCP ...
2
votes
1answer
30 views

Function of an VEGF inhibitor in the treatment of macular degeneration

I'm working on a short presentation of treatments of macular degeneration for a biomedical optics seminar on macular degeneration. Since I don't have any relevant medical or biological background ...
1
vote
1answer
52 views

Dimethyltryptamine and Sigma 1-type opioid receptor interaction

Where exactly do dimethyltryptamine and sigma 1-type opioid receptor interact? I read in this When the Endogenous Hallucinogenic Trace Amine N,N-Dimethyltryptamine Meets the Sigma-1 Receptor but it ...
1
vote
0answers
80 views

Why can't sodium butyrate be delivered orally in humans and other mammals?

I think I know why -- bioavailability problems but since I have no firm evidence to support this theory I thought I would ask the biology stackexchange community for their input. I'd like some firm ...